Key statistics
On Friday, CAMP4 Therapeutics Corp (CAMP:NMQ) closed at 3.85, 195.02% above the 52 week low of 1.31 set on Jun 20, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 4.46 |
|---|---|
| High | 4.52 |
| Low | 3.85 |
| Bid | 3.50 |
| Offer | 4.62 |
| Previous close | 4.39 |
| Average volume | 57.24k |
|---|---|
| Shares outstanding | 51.88m |
| Free float | 44.12m |
| P/E (TTM) | -- |
| Market cap | 227.75m USD |
| EPS (TTM) | -2.48 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
- CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference
- CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock
- CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries
- CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights
- CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01
- CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders
- CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights
More ▼
